Dudediligence.

Ionis Pharmaceuticals, Inc

IONSNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$133.8MSep ’24$226.6MDec ’24$131.6MMar ’25$452.0MJun ’25$156.7MSep ’25$203.3MDec ’25$246.1MMar ’26$267.9MJun ’26
Net income, by quarter
−$140.5MSep ’24−$104.3MDec ’24−$146.9MMar ’25$123.6MJun ’25−$128.6MSep ’25−$229.4MDec ’25−$92.5MMar ’26−$114.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$810.5M$587.4M$787.6M$705.1M$943.7M
Gross profit$799.6M$573.3M$778.5M$693.9M$927.8M
Operating income−$30.2M−$410.2M−$353.7M−$475.1M−$381.7M
Net income−$28.6M−$269.7M−$366.3M−$453.9M−$381.4M
Operating cash flow$30.8M−$274.4M−$307.5M−$500.9M−$268.6M
Free cash flow$18.8M−$290.1M−$331.3M−$546.2M−$320.0M
Cash$869.2M$276.5M$399.3M$242.1M$372.3M
Debtnone on file$1.18B$1.24B$1.20B$1.76B
Shares outstanding141.2M142.1M144.3M157.9M163.3M